RID partners with DynaLIFE
DynaLIFE Medical Labs and RID Inc. are launching the first evaluation of the Hopper™ platform for urinary tract infection diagnostics. Tests commence summer 2021.
Previous
Previous
Calgary-led team develops rapid diagnostic tool for fighting bloodstream infections
Next
Next